Reading an ultrasound is hard — it takes years of training to recognise subtle differences between normal and diseased tissue. AI is changing that. The US ultrasound devices market forecast predicts that AI‑powered ultrasound will be a $500 million sub‑market by 2030. Algorithms can measure ejection fraction, detect nodules, and even suggest diagnoses — all in seconds.

What's already available? Automated breast volume scanning (ABVS) for cancer screening, and AI that guides novice users to the correct imaging plane. The US ultrasound devices market analysis notes that the fastest‑growing technology is wireless communication — devices that stream images directly to the cloud for AI analysis.

But AI isn't perfect. It can miss rare findings or be fooled by artefacts. And it raises legal questions: who's liable if the AI misses a cancer?

The bottom line: AI won't replace sonographers, but it will make them faster and more accurate. Embrace it, but don't trust it blindly. Human oversight is still essential.